vs
Side-by-side financial comparison of reAlpha Tech Corp. (AIRE) and Applied Therapeutics, Inc. (APLT). Click either name above to swap in a different company.
Applied Therapeutics, Inc. is the larger business by last-quarter revenue ($1.0M vs $895.3K, roughly 1.1× reAlpha Tech Corp.). reAlpha Tech Corp. runs the higher net margin — -541.6% vs -1899.0%, a 1357.4% gap on every dollar of revenue. On growth, Applied Therapeutics, Inc. posted the faster year-over-year revenue change (719.7% vs 70.1%).
reAlpha Tech Corp is a proptech firm that leverages artificial intelligence to identify, acquire, and operate high-yield short-term residential rental properties primarily across the United States. It provides tech-powered property management solutions to enhance guest experiences and maximize returns for individual and institutional real estate investors.
Relief Therapeutics is a Swiss biopharmaceutical company based in Geneva. The company focuses on developing drugs for serious diseases with few or no existing treatment options. Its lead compound, RLF-100, is a synthetic form of a natural peptide that protects the lung. The company was incorporated as Relief Therapeutics Holdings AG (RFLB.S) and listed on the SIX Swiss Exchange in 2016.
AIRE vs APLT — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $895.3K | $1.0M |
| Net Profit | $-4.8M | $-19.0M |
| Gross Margin | 62.7% | — |
| Operating Margin | -507.8% | -1675.8% |
| Net Margin | -541.6% | -1899.0% |
| Revenue YoY | 70.1% | 719.7% |
| Net Profit YoY | 76.9% | 72.3% |
| EPS (diluted) | $-0.02 | $-0.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $895.3K | — | ||
| Q3 25 | $1.4M | $1.0M | ||
| Q2 25 | $1.3M | $0 | ||
| Q1 25 | $925.6K | $0 | ||
| Q4 24 | $526.4K | $-1.0K | ||
| Q3 24 | $339.2K | — | ||
| Q2 24 | $62.4K | $144.0K | ||
| Q1 24 | $20.4K | $190.0K |
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-5.8M | $-19.0M | ||
| Q2 25 | $-4.1M | $-21.3M | ||
| Q1 25 | $-2.8M | $-21.8M | ||
| Q4 24 | $-21.0M | $44.0M | ||
| Q3 24 | $-2.1M | — | ||
| Q2 24 | $-1.5M | $2.9M | ||
| Q1 24 | $-1.4M | $-83.9M |
| Q4 25 | 62.7% | — | ||
| Q3 25 | 51.9% | — | ||
| Q2 25 | 49.6% | — | ||
| Q1 25 | 56.0% | — | ||
| Q4 24 | 71.1% | — | ||
| Q3 24 | 66.6% | — | ||
| Q2 24 | 70.7% | — | ||
| Q1 24 | 10.7% | — |
| Q4 25 | -507.8% | — | ||
| Q3 25 | -342.4% | -1675.8% | ||
| Q2 25 | -326.5% | — | ||
| Q1 25 | -261.7% | — | ||
| Q4 24 | -524.6% | 3302300.0% | ||
| Q3 24 | -479.1% | — | ||
| Q2 24 | -1939.6% | -14194.4% | ||
| Q1 24 | -6397.0% | -11101.6% |
| Q4 25 | -541.6% | — | ||
| Q3 25 | -400.1% | -1899.0% | ||
| Q2 25 | -328.3% | — | ||
| Q1 25 | -307.9% | — | ||
| Q4 24 | -3994.4% | -4400700.0% | ||
| Q3 24 | -618.6% | — | ||
| Q2 24 | -2370.9% | 2012.5% | ||
| Q1 24 | -6946.9% | -44177.9% |
| Q4 25 | $-0.02 | — | ||
| Q3 25 | $-0.07 | $-0.13 | ||
| Q2 25 | $-0.08 | $-0.15 | ||
| Q1 25 | $-0.06 | $-0.15 | ||
| Q4 24 | $-0.47 | $0.52 | ||
| Q3 24 | $-0.05 | — | ||
| Q2 24 | $-0.03 | $-0.13 | ||
| Q1 24 | $-0.03 | $-0.67 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.8M | $11.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $11.5M | $-561.0K |
| Total Assets | $21.7M | $34.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.8M | — | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | $587.3K | $30.4M | ||
| Q1 25 | $1.2M | $50.8M | ||
| Q4 24 | $3.1M | $79.4M | ||
| Q3 24 | $7.1M | — | ||
| Q2 24 | $3.7M | $122.2M | ||
| Q1 24 | $4.8M | $146.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | $152.9K | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $241.1K | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $11.5M | — | ||
| Q3 25 | $10.9M | $-561.0K | ||
| Q2 25 | $-1.1M | $17.4M | ||
| Q1 25 | $-972.3K | $36.7M | ||
| Q4 24 | $1.6M | $57.0M | ||
| Q3 24 | $22.5M | — | ||
| Q2 24 | $22.2M | $72.4M | ||
| Q1 24 | $23.3M | $67.3M |
| Q4 25 | $21.7M | — | ||
| Q3 25 | $19.7M | $34.4M | ||
| Q2 25 | $15.5M | $37.3M | ||
| Q1 25 | $18.5M | $56.9M | ||
| Q4 24 | $12.0M | $86.7M | ||
| Q3 24 | $34.2M | — | ||
| Q2 24 | $24.6M | $127.8M | ||
| Q1 24 | $25.4M | $151.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.15× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.3M | $-18.4M |
| Free Cash FlowOCF − Capex | $-11.3M | — |
| FCF MarginFCF / Revenue | -1262.7% | — |
| Capex IntensityCapex / Revenue | 4.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-20.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-4.2M | $-18.4M | ||
| Q2 25 | $-2.3M | $-20.3M | ||
| Q1 25 | $-2.3M | $-28.6M | ||
| Q4 24 | $-6.0M | $-19.5M | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | $-1.0M | $-22.6M | ||
| Q1 24 | $-1.5M | $-18.9M |
| Q4 25 | $-11.3M | — | ||
| Q3 25 | $-4.3M | — | ||
| Q2 25 | $-2.3M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-1.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -1262.7% | — | ||
| Q3 25 | -294.1% | — | ||
| Q2 25 | -187.5% | — | ||
| Q1 25 | -246.4% | — | ||
| Q4 24 | -1150.2% | — | ||
| Q3 24 | -372.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 0.4% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 1.5% | — | ||
| Q4 24 | 2.4% | — | ||
| Q3 24 | 2.2% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.44× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -7.80× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
